Trizmox-625 Tablet
Product Overview
Product Overview
Trizmox-625 is a potent, broad-spectrum antibiotic formulation that combines Amoxicillin 500 mg with Clavulanic Acid 125 mg. This synergistic combination enhances the antibiotic’s effectiveness against β-lactamase-producing bacterial strains, providing reliable treatment for a wide range of infections involving the respiratory tract, urinary tract, skin, bones, and joints.
Key Benefits
-
Broad coverage against Gram-positive and Gram-negative bacteria
-
Combats resistant bacterial infections
-
Excellent tissue penetration for faster recovery
-
Clinically proven and well tolerated
Compositions
Compositions
| Form | Ingredient / Strength | Role / Class |
|---|---|---|
| Film-coated Tablet | Amoxicillin (as Trihydrate) 500 mg | Penicillin antibiotic |
| Film-coated Tablet | Potassium Clavulanate (as Clavulanic Acid) 125 mg | β-lactamase inhibitor |
| Excipients | q.s. | — |
| Colour | Titanium Dioxide | — |
Indications
Trizmox-625 is indicated for the treatment of infections caused by susceptible organisms, including:
-
Respiratory tract infections (bronchitis, pneumonia, sinusitis)
-
ENT infections (otitis media, tonsillitis, pharyngitis)
-
Urinary tract infections (cystitis, pyelonephritis)
-
Skin and soft-tissue infections
-
Bone and joint infections
-
Dental infections
Dosage & Administration
Administer orally as prescribed by the physician. Typically taken every 12 hours with food or immediately before meals to minimize gastrointestinal irritation and improve absorption. Do not discontinue the course prematurely.
Precautions / Warnings
-
Contraindicated in patients with known hypersensitivity to penicillins or β-lactam antibiotics
-
Use with caution in hepatic or renal impairment
-
May cause mild gastrointestinal upset in some patients
-
Prolonged use may lead to secondary infections; use only as directed
-
Keep out of reach of children
Storage
Store below 25 °C in a cool, dry place. Protect from light and moisture.
